160 related articles for article (PubMed ID: 38247803)
1. A Novel Protozoa Parasite-Derived Protein Adjuvant Is Effective in Immunization with Cancer Cells to Activate the Cancer-Specific Protective Immunity and Inhibit the Cancer Growth in a Murine Model of Colorectal Cancer.
Mani R; Martin CG; Balu KE; Wang Q; Rychahou P; Izumi T; Evers BM; Suzuki Y
Cells; 2024 Jan; 13(2):. PubMed ID: 38247803
[TBL] [Abstract][Full Text] [Related]
2. Immunization with the amino-terminus region of dense granule protein 6 (GRA6) of Toxoplasma gondii activates CD8
Mani R; Mercier C; Delauw MF; Suzuki Y
Microbes Infect; 2023; 25(8):105182. PubMed ID: 37423326
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; El Bissati K; Zhou Y; Suzuki Y; Lee D; Woods S; Sommerville C; Henriquez FL; Roberts CW; McLeod R
Hum Immunol; 2012 Jan; 73(1):1-10. PubMed ID: 22027386
[TBL] [Abstract][Full Text] [Related]
4. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.
Khan IA; Kasper LH
J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
Osorio Y; Ghiasi H
J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
[TBL] [Abstract][Full Text] [Related]
6. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.
Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Nishitani M; Ishikawa H; Himeno K
Immunology; 2001 Nov; 104(3):289-98. PubMed ID: 11722643
[TBL] [Abstract][Full Text] [Related]
7. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
Zorgi NE; Galisteo AJ; Sato MN; do Nascimento N; de Andrade HF
Med Microbiol Immunol; 2016 Aug; 205(4):297-314. PubMed ID: 26732075
[TBL] [Abstract][Full Text] [Related]
8. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
Meraldi V; Romero JF; Kensil C; Corradin G
Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
[TBL] [Abstract][Full Text] [Related]
9. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
Khan IA; Casciotti L
J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ production by brain-resident cells activates cerebral mRNA expression of a wide spectrum of molecules critical for both innate and T cell-mediated protective immunity to control reactivation of chronic infection with
Suzuki Y; Lutshumba J; Chen KC; Abdelaziz MH; Sa Q; Ochiai E
Front Cell Infect Microbiol; 2023; 13():1110508. PubMed ID: 36875520
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
Yamaguchi S; Tatsumi T; Takehara T; Sakamori R; Uemura A; Mizushima T; Ohkawa K; Storkus WJ; Hayashi N
Cancer; 2007 Oct; 110(7):1469-77. PubMed ID: 17685394
[TBL] [Abstract][Full Text] [Related]
12. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
13. Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of
Sa Q; Ochiai E; Tiwari A; Mullins J; Shastri N; Mercier C; Cesbron-Delauw MF; Suzuki Y
J Immunol; 2017 Jun; 198(11):4425-4434. PubMed ID: 28446567
[No Abstract] [Full Text] [Related]
14. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice.
Khan IA; Ely KH; Kasper LH
J Immunol; 1991 Nov; 147(10):3501-6. PubMed ID: 1940350
[TBL] [Abstract][Full Text] [Related]
15. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
Front Immunol; 2020; 11():583382. PubMed ID: 33240271
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii.
Jordan KA; Wilson EH; Tait ED; Fox BA; Roos DS; Bzik DJ; Dzierszinski F; Hunter CA
Infect Immun; 2009 Sep; 77(9):3894-901. PubMed ID: 19528214
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
Eguchi J; Hiroishi K; Ishii S; Mitamura K
Cancer Immunol Immunother; 2003 Jun; 52(6):378-86. PubMed ID: 12739068
[TBL] [Abstract][Full Text] [Related]
18. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.
Lu G; Zhou A; Meng M; Wang L; Han Y; Guo J; Zhou H; Cong H; Zhao Q; Zhu XQ; He S
BMC Infect Dis; 2014 Dec; 14():3862. PubMed ID: 25527277
[TBL] [Abstract][Full Text] [Related]
19. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
